|

Ultomiris Clinical Trials

1 actively recruiting trial across 1 location

Also known as: There is no interventional drug. Ultomiris treatment is an inclusion criterion.

Top Sponsors

  • Alexion Pharmaceuticals, Inc.1

Indications

  • Neuromyelitis Optica Spectrum Disorder (NMOSD)1
  • Generalized Myasthenia Gravis (gMG)1
  • Atypical Hemolytic Uremic Syndrome (aHUS)1
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)1
  • Pregnancy1

Boston, Massachusetts1 trial

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Research Site

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.